Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Squamous Cell × Aspirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 7 Colonic Neoplasms 6 Recurrence 4 Prostatic Neoplasms 4 Neoplasms 3 Venous Thromboembolism 2 Rectal Neoplasms 2 Polycythemia Vera 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Cardiovascular Diseases 2 Adenoma 2 Vascular Diseases 1 Thrombosis 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Pathologic Processes 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lynch syndrome I (site-specific colonic cancer) 1 Lymphoma, Follicular 1 Ischemic Stroke 1 Intestinal Neoplasms 1

Interventions

Cisplatin 7 Docetaxel 5 Paclitaxel 4 pembrolizumab 3 Radiotherapy 3 Carboplatin 3 figitumumab 2 cemiplimab 2 Radiation 2 Methotrexate 2 Fluorouracil 2 Drug Therapy 2 Cetuximab 2 Bleomycin 2 vandetanib 1 talimogene laherparepvec 1 sintilimab 1 nedaplatin 1 nanocis 1 methyl 5-aminolevulinate 1 ficlatuzumab 1 dusquetide 1 brigatinib 1 alpha-2'-deoxythioguanosine 1 advexin 1 Vinorelbine 1 Tretinoin 1 Tirapazamine 1 Technetium-99 1 TP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01496521 2011-12-21

CREAT

Beijing Friendship Hospital

Phase 3 Unknown

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡